A BuiltForAI Property
Live data · NADAC + Part D CY24 · reviewed daily

Olmesartan Medoxomil and Hydrochlorothiazide

Olmesartan Medoxomil and Hydrochlorothiazide reduces fluid retention and lowers blood pressure by increasing urine output.

First FDA approval2017-04-24
Generic availableYes · 10 mfrs
Shortage statusNone
340B exposureunknown
Last updated
NADAC: weekly (every Wed)Part D Formulary: quarterlyPart D Spend: annual (CY24)Orange Book: weeklyShortages: daily
At a glance · the numbers a plan sponsor wants on screen one
Lowest NADAC
$0.169/unit
20 NDCs benchmarked, lowest of all strengths.
Average NADAC
$0.181
Across all dosage forms in distribution.
Highest NADAC
$0.216
Range is tight.
Plans with PA
0 / 329
Zero PA friction — switching is purely formulary.

Questions a plan sponsor actually asks.

FAQPage schema8 entries indexed · 4 visible
What is Olmesartan Medoxomil and Hydrochlorothiazide used for?

Olmesartan Medoxomil and Hydrochlorothiazide reduces fluid retention and lowers blood pressure by increasing urine output.

Is there a generic for Olmesartan Medoxomil and Hydrochlorothiazide?

Yes. 30 ANDAs filed at FDA, 10 generic manufacturers currently shipping.

How much does my plan pay for Olmesartan Medoxomil and Hydrochlorothiazide?

Across 329 Part D plans, Olmesartan Medoxomil and Hydrochlorothiazide averages $0.181/unit (NADAC). Lowest available: $0.169/unit. Highest in distribution: $0.216/unit.

Is Olmesartan Medoxomil and Hydrochlorothiazide on the FDA shortage list?

No. Olmesartan Medoxomil and Hydrochlorothiazide is not currently on the FDA Drug Shortage Database.

4 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.

Same class. Different math.

Thiazide Diuretic6 alternatives in D1
01
Losartan and Hydrochlorothiazide
Brand: HYZAAR
$0.065Lowest NADAC
10Generic mfrs
CY24 Part D spend
Compare →
02
Hydrochlorothiazide
Brand: INZIRQO
$0.012Lowest NADAC
11Generic mfrs
$122.0MCY24 Part D spend
Compare →
03
Bisoprolol and Hydrochlorothiazide
Thiazide Diuretic
$0.195Lowest NADAC
8Generic mfrs
CY24 Part D spend
Compare →
04
Valsartan and Hydrochlorothiazide
Brand: Diovan HCT
$0.124Lowest NADAC
7Generic mfrs
CY24 Part D spend
Compare →
05
Triamterene and Hydrochlorothiazide
Thiazide Diuretic
$0.096Lowest NADAC
8Generic mfrs
CY24 Part D spend
Compare →
06
Lisinopril and Hydrochlorothiazide Tablets
Brand: Lisinopril and Hydrochlorothiazide
$0.029Lowest NADAC
0Generic mfrs
CY24 Part D spend
Compare →

Sources · every number above traces back.

Last refresh30 May 2026

Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (10 approvals on file) · NADAC unit costs: CMS NADAC weekly file (20 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.